InvestorsHub Logo
Followers 3173
Posts 153190
Boards Moderated 4
Alias Born 06/03/2011

Re: StaleyCornell post# 1793

Friday, 02/28/2020 10:49:45 AM

Friday, February 28, 2020 10:49:45 AM

Post# of 6214
Just saw this sticky..

Wow..

Exciting is an understatement..

This is exciting stuff on Vaxart.

https://insiderfinancial.com/top-coronavirus-stocks-backed-by-scientific-evidence/179657/

"Vaxart Inc. (NASDAQ: VXRT) has a core competency in oral recombinant protein vaccines but is expanding indications to work on a possible vaccine against Covid-19. Since the vaccine is in the form of a tablet it lends itself to much wider adoption should it be approved. Studies have shown that it is just as effective as the seasonal vaccine Fluzone manufactured by SNY. The market cap is only $80 million so any positive approval news could vault the stock price."

Just as effective as SNY!!! SNY trades at $48 per share with a 10.4 billion market cap. Just sayin!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VXRT News